Skip media
Antiseptics

Hibiwash

Hibiwash® is an antimicrobial preparation for pre-operative surgical hand disinfection, antiseptic hand washing on the ward and pre-operative and post- operative skin antisepsis for patients undergoing elective surgery.

  • {{ feature }}

  3. Both Surgical site infections ( SSIs) and Healthcare acquired infections (HCAIs ) demand a coordinated approach pre-and post-surgery by healthcare professionals and their patients. Hibiwash® is your trusted partner in helping prevent infections, promote skin’s integrity and save time before performing surgical procedures. It contains 4% Chlorhexidine Gluconate for a wide range of antimicrobial activity and has been used for many decades in hospitals. Regular use of Hibiwash® can help reduce the chance of 11 in 100 patients contracting an SSI up to 30 days after surgery. It has also been shown to significantly decrease the risk of hospital-associated Staphylococcus aureus infections by up to 60% when used in combination with a nasal antibiotic. Hibiwash® is not absorbed into the skin but binds to it to form a protective layer that removes and kills microorganisms and continues to do so for a long period of time after application. Unlike povidone iodine, Hibiwash® is not inactivated by bodily fluids. Hibiwash® has been reformulated to be a more sustainable product, using fewer raw materials and less energy in its production. The removal of colour, fragrance and traces of soya oil makes it less likely to create skin irritation or an allergic reaction and has the potential of an increased compliance. It also contains emollients and it is gentle on the skin even with frequent use.

    1. 01

      Chlorhexidine Gluconate in Hibiwash® is effective against a wide range of microbes including several strains of Gram positive and Gram negative bacteria, yeast, fungi and viruses, and chlorhexidine reduces bacterial load more efficiently than povidone iodine

    2. 02

      In a small study Hibiwash® reduced skin flora by 94% with the first whole body wash and then by a further 77% with the second

    3. 03

      Chlorhexidine Gluconate in Hibiwash® is not absorbed into the skin but binds to it, forming a protective layer even after rinsing, and efficiently kills bacteria for several hours after application. Additionally, unlike povidone iodine, Chlorhexidine Gluconate based products are not inactivated by bodily fluids, blood and pus

    4. 04

      Hibiwash® is dermatologically tested and enhanced with emollients. It has been shown to be gentle on the skin even when used frequently. Repeated application of Chlorhexidine Gluconate containing products, such as Hibiwash® has been shown to increase antimicrobial efficacy

    5. 05

      Hibiwash® is suitable for surgical hand washing prior to an operation. It is highly efficacious, kills and removes a vast number of microorganisms. It is also suitable for hygienic hand washing on the Ward

    6. 06

      Hibiwash® contains 4% Chlorhexidine Gluconate for a wide range of antimicrobial activity

    7. 07

      Regular use of Hibiwash® can help reduce the chance of 11 in 100 patients contracting an SSI up to 30 days after surgery. It has also been shown to significantly decrease the risk of hospital-associated Staphylococcus aureus infections by up to 60% when used in combination with a nasal antibiotic

    1. Garibaldi RA. Journal of Hospital Infection 1988; 11: 5-9
    2. Menon, V. Chapter 22 Sixth Edition 2021; Pages 477-506
    3. Jarral O et all 2011
    4. Byrne DJ et al. Journal of Hospital Infection 1990; 15:183-187
    5. Sheikh W. Current Therapeutic Research 1986;40(6): 1096-1102
    6. Faoagali et al. American Journal of Infection Control 2 1995
    7. Menon, V. Chapter 22 Sixth Edition 2021; Pages 477-506
    8. Case DE., Chlorhexidine: Attempt to detect percutaneous absorption in man, Proceedings of the 9th International Congress of Chemotherapy, J.D. Williams & A.M. Geddes ED., 1976;3 (Chemotherapy): 367-374.
    9. Mölnlycke Health Care. Internal Report REPR0495. Data on file
    10. Tanner J et al. A fresh look at perioperative body washing. Journal of Infection Prevention. 2012; (13) 11 - 15.
    11. Faoagali et al. American Journal of Infection Control 2 1995
    12. Molnlycke Internal Report REPR0781 (patch test study)
    13. Molnlycke Internal Report REPR1037
    14. Molnlycke Internal Report REPR1130
    15. SmPC
    16. Molnlycke Internal Report REPR0781 (patch test study)
    17. Mölnlycke Health Care. Data on file.
    18. SmPC
    19. Gillespie B.M. 2021. Worldwide incidence of surgical site infections in general surgical patients: A systematic review and meta-analysis of 488,594 patients. International Journal of Surgery, 95, p.106136.
    20. Bode LGM et al. Preventing Surgical Site Infections in Nasal Carriers of Staphylococcus aureus. The New England Journal of Medicine 2010; 362(1): 9-17.
  5. Packaging level Quantity (pcs) GTIN code
    {{ row.packagingLevel }} {{ row.quantity }} {{ row.gtinCode }}

    {{ item.key }}: {{ item.value }}

Related products

Show all